Next Article in Journal
Risk Factors, Clinical Characteristics, and Prognosis of Acute Kidney Injury in Hospitalized COVID-19 Patients: A Retrospective Cohort Study
Previous Article in Journal / Special Issue
Erectile Dysfunction Treatment Using Stem Cells: A Review
Open AccessReview

Neurogenic Erectile Dysfunction. Where Do We Stand?

1
Urology Department, General Hospital of Corinth, 20131 Corinth, Greece
2
Urology & Neurourology Unit, National Rehabilitation Center, Ilion, 13122 Athens, Greece
*
Author to whom correspondence should be addressed.
Received: 14 October 2020 / Revised: 16 December 2020 / Accepted: 4 January 2021 / Published: 7 January 2021
Erectile Dysfunction (ED) is the persistent inability to attain and maintain an erection sufficient to permit satisfactory sexual performance, causing tremendous effects on both patients and their partners. The pathophysiology of ED remains a labyrinth. The underlying mechanisms of ED may be vasculogenic, neurogenic, anatomical, hormonal, drug-induced and/or psychogenic. Neurogenic ED consists of a large cohort of ED, accounting for about 10% to 19% of all cases. Its diversity does not allow an in-depth clarification of all the underlying mechanisms nor a “one size fits all” therapeutical approach. In this review, we focus on neurogenic causes of ED, trying to elucidate the mechanisms that lie beneath it and how we manage these patients. View Full-Text
Keywords: erectile dysfunction (ED); neurogenic; sexual dysfunction (SD); phosphodiesterase type-5 inhibitors (PDE5I); spinal cord injury (SCI); multiple sclerosis (MS) erectile dysfunction (ED); neurogenic; sexual dysfunction (SD); phosphodiesterase type-5 inhibitors (PDE5I); spinal cord injury (SCI); multiple sclerosis (MS)
Show Figures

Figure 1

MDPI and ACS Style

Thomas, C.; Konstantinidis, C. Neurogenic Erectile Dysfunction. Where Do We Stand? Medicines 2021, 8, 3. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines8010003

AMA Style

Thomas C, Konstantinidis C. Neurogenic Erectile Dysfunction. Where Do We Stand? Medicines. 2021; 8(1):3. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines8010003

Chicago/Turabian Style

Thomas, Charalampos; Konstantinidis, Charalampos. 2021. "Neurogenic Erectile Dysfunction. Where Do We Stand?" Medicines 8, no. 1: 3. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines8010003

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop